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e16 Abstractsm, p ¼ 0.017), MWD (80 (50e118.5) vs 111.5 (91.3e210.3) m,
p ¼ 0.013) and PRWD (201.5 (100e295) vs 382.5 (187.3e550) m,
p < 0.001). VascuQol score was also signiﬁcantly improved: 4.7
(3.8e5.3) vs 5.4 (5.2e5.7), p < 0.001. Patients in the control group
did not demonstrate any signiﬁcant differences in CD (28 (11e41)
vs 26 (24e49) m, p ¼ 0.26), MWD (53.5 (43e70) vs 69 (50e91) m,
p ¼ 0.107), PRWD (120 (55e220) vs 102.5 (55e250) m, p ¼ 0.50)
or VascuQol score (2.8 (2.8e5.0) vs 3.2 (2.4e5.2), p ¼ 0.64).
At 3-months signiﬁcantly higher improvements were seen in the
NFB group, as compared to the control group, for VascuQol score
(0.8 (0.4e1) vs 0.04 (0.3e0.3), p ¼ 0.004) and PRWD (143.5
(51.3e309) vs 0 (0e5) m, p ¼ 0.015), but not for MWD (15.5
(3e58.3) vs 20 (5e48), p ¼ 0.78) or CD (11.5 (1e22.3) vs 8
(5e10) m, p ¼ 0.32).
At 3-months the use of wearable activity tracker technology
improved PRWD and QoL to a greater extent than standard con-
servative therapy and may be used to encourage exercise habits.
NCT01822457 (http://www.clinicaltrials.gov)
Catheter Delivered Treatment (CDT) for Deep Vein Thrombosis. A
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NICE guidance recommends consideration of CDT for proximal
DVT, with the aim of preventing post-thrombotic syndrome. This
study aimed to review practice in CDT for DVT across the North
West of England.
Retrospective case note review of all CDT for DVT between
March 2012eApril 2014. The following data was collected from
four vascular units covering a population of 2.9 million: patient
demographics, risk factors, site, interval from presentation to
intervention, intervention, complications and follow up.
Of 2560 cases of DVT identiﬁed, only 15 cases underwent CDT
(0.58%). Patients were mostly females (11F:4M) with median age 43
years (16e64). Twelve patients underwent catheter thrombolysis and
3 mechanical thrombectomy. Median treatment duration was 36
hours (range 1e9 6). IVC ﬁlter was deployed in 6 patients and veno-
plasty/stenting performed in six. Complete lysis was achieved in 13
patients. There were two bleeding complications; one minor, one
major (managed conservatively).NopatientshadPE.Median inpatient
stay was 7 days (range 5e23) and follow up range was 6e24 months.
CDTwas safe and effective though the number treated was lower
than would be expected and signiﬁcant variation in practice was
noted between units. Vigilance should be heightening amongst
admitting physicians to ensure that patients who would beneﬁt
from CDT are referred acutely to their regional vascular unit.
Keeping an Eye on the Target: Direct or Indirect Revascularisation
of the Angiosome?
A.E. Sharrock 1, T. Barker 2, E.L. Kershaw 3, C. Watts 4
1 NHLI, Imperial College, London, UK
2 Department of Vascular Surgery, Queen Elizabeth Hospital, West Midlands, UK
3 Department of General Surgery, Southampton General Hospital, Hampshire, UK
4 Department of Radiology, Salisbury District Hospital, Wiltshire, UK
It has been postulated that direct revascularisation (DR) of tribu-
tary vessels supplying a foot ulcer may have superior outcome in
terms of wound healing and amputation when compared toindirect revascularisation (IR). This study aims to clarify this hy-
pothesis in diabetic patients with Rutherford 5/6 skin changes.
A six year retrospective single-centre analysis of diabetic patients
with Rutherford 5/6 distal lower limb skin changes undergoing an
associated angioplasty was undertaken. All interventions were
performed using a standardised technique. Healing, amputation
and mortality data was recorded over 36 months. A provisional
analysis was performed of 60 patients, then formalised in 72.
72 patients were included. No differences were identiﬁed be-
tweenDR and IR in groups formedian time to healing (152.0 days and
144.0 days respectively) (p¼ NS), mortality (p¼ NS) or amputation.
This study adds to the few published studies which assess
outcomes by targeted revascularisation in diabetic patients. The
authors recommend maximising blood ﬂow through both direct
and indirect revascularisation.
Combined Infra-popliteal Angioplasty has no Advantage over
Direct Angiosomal Revascularisation
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Meta-analysis has shown direct (the artery leading directly to the
tissue loss) angiosomal reperfusion to be superior to indirect reper-
fusion. Someunits perform combined (direct and indirect i.e. open up
as many tibial vessels as possible) reperfusion of the tibial vessels.
There was inadequate data published on combined tibial angioplasty
to performmeta-analysis in 2014. Our unit performs combined infra-
popliteal angioplasty routinely, where possible, so the aim was to
assess any advantage over traditional direct or indirect tibial angio-
plasty and to examine the effect of diabetes on the angiosomemodel.
Analysis of consecutive infra-popliteal angioplasties over a 5-
year period. Kaplan Meier survival curves were used to examine
differences between groups; p-values were corrected. Combined
angioplasty was performed routinely wherever possible.
Two hundred and sixteen tibial angioplasties were performed.
24.5% underwent combined revascularisation, 52.3% direct and
23.1% indirect. There was a signiﬁcant improvement in amputation
free survival (Hazard Ratio HR ¼ 1.652, p ¼ 0.019) in the direct
and combined groups over indirect revascularisation. However,
there was no improvement in wound healing (HR ¼ 1.163,
p ¼ 0.117). The direct vs combined comparisons showed no dif-
ference for any outcome (wound healing HR ¼ 0.947, p ¼ 0.849
and amputation HR ¼ 0.971, p ¼ 0.906). All trends were lost in
diabetic patients alone (n ¼ 149, 69% of group).
In this the largest series of combined angioplasty in the litera-
ture there was no advantage in opening up all the tibial vessels
with angioplasty if the angiosome directly supplying the ischaemic
tissue could be opened. The angiosome model does not appear
valid, however, in diabetic patients.
The Endovascular Sealing Device in Combination with Parallel
Grafts to treat Juxta- and Suprarenal Aneurysms
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The chimney technique offers an alternative to fenestrated/
branched endovascular solutions for juxtarenal and suprarenal
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device may offer some advantages with respect to seal between
the endograft and chimney grafts. This study aimed to investigate
the feasibility and efﬁcacy of the Nellix Endovascular Aneurysm
Sealing (EVAS) system in conjunction with chimney grafts.
A prospective evaluation of patients treated for juxtarenal and
suprarenal non-ruptured aortic aneurysms using the Nellix system
and chimney grafts was undertaken in a single Vascular Unit in the
United Kingdom.
Between February 2013 and April 2015 28 patients were
treated with EVAS in a chimney graft conﬁguration. Mean age was
74 years (8 years) and mean aneurysm size 67 mm (10 mm).
Eight patients underwent suprarenal aneurysm repair including a
chimney graft in the superior mesenteric artery. Five patients had
a double chimney conﬁguration; all the other patients were
treated with a single chimney conﬁguration. There was one 30-day
or in-hospital mortality (3.6%) due to Multi-Organ Failure (MOF)
after repair of a symptomatic aneurysm; three other patients died
within one year, due to pancreatic cancer (diagnosed after sur-
gery), pneumonia, and sepsis respectively. One patient experi-
enced a transient ischemic attack (TIA), followed by a full recovery
and two patients suffered from a minor stroke (7%). No patient
required postoperative renal replacement therapy.
The chimney technique, in combination with endovascular
aneurysm sealing, appears to offer an effective solution for jux-
tarenal and suprarenal aneurysms with adverse morphology in the
short-term.
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Three-dimensional (3D) fusion computed tomography (CT) is a
new technology that may reduce radiation in FEVAR (fenestrated
endovascular aneurysm repair). The aim of this study was to
evaluate the radiation dose effect of introducing fusion imaging to
an expert team.
Procedural details were gathered prospectively 18 consecutive
patients receiving fusion-guided (Fusion Group) FEVAR and
compared with 21 patients treated in the 12 months prior to the
implementation of routine fusion imaging (Standard Group). Pro-
cedure time (PT), radiation dose, dose-area product (DAP), ﬂuo-
roscopy time (FT), estimated blood loss (EBL) and pre- and post-
operative estimated glomerular ﬁltration rate (eGFR) were
compared between groups.
The Fusion group (n ¼ 18) received three 2 vessel-, ten 3 vessel-
, four 4 vessel-, and one single vessel-fenestrated graft(s). The
Standard group (n ¼ 21) received ﬁve 4 vessel-, eleven 3 vessel-,
four 2 vessel-, and one single-vessel graft(s). There was a signiﬁ-
cant reduction in PT for the Fusion group (median 285 mins;
interquartile range 265e323) compared with the Standard group
(420 mins; IQR 330e310 p ¼ <0.001). There were signiﬁcant re-
ductions in radiation skin dose for the Fusion group (1.65 Gy;
1.22e2.22) compared with the Standard group (4.39 Gy; 3.28e
7.05 p ¼ <0.001), and DAP; Fusion (173.64 Gy cm2; 138.33e
232.77) vs (264.93 Gy cm2; 173.37e366.85) for Standard
(p ¼ 0.001). EBL was reduced for Fusion (350 mls; 250e560)compared with Standard (1000 mls; 420e2300 p ¼ 0.01). There
was no difference in FT.
Implementation of fusion imaging signiﬁcantly reduces radia-
tion dose and other performance measures, and improves the
overall safety proﬁle of FEVAR.Endovascular Aneurysm Sealing for Infrarenal Abdominal Aortic
Aneurysms: 30-Day Outcomes of 105 Patients in a Single Centre
J.R.W. Brownrigg, J. de Bruin, A. Karthikesalingam, B. Patterson,
P.J. Holt, R.J. Hinchliffe, R. Morgan, I.M. Loftus, M.M. Thompson
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Endovascular aneurysm sealing (EVAS) is a potential alternative to
endovascular aneurysm repair (EVAR) in patients with infrarenal
abdominal aortic aneurysms (AAA). The early clinical experience,
technical reﬁnements, and learning curve of EVAS in the treatment
of AAA at a single institution are presented.
105 patients were treated with EVAS between March 2013 and
November 2014. Prospective data were recorded on consecutive
patients receiving EVAS, including demographics aneurysm
morphology, and 30-day outcomes, including rates of endoleak,
limb occlusion, reintervention, and death. Postoperative imaging
consisted of duplex ultrasound and computed tomographic
angiography.
Mean age was 76  8 years and 12% were female. Adverse neck
morphology was present in 72 (69%) patients, including aneurysm
neck length <10 mm (20%), neck diameter >32 mm (18%), b-
angulation >60 (21%), and conical aneurysm neck (51%). One
death and four Type 1 endoleaks (4%) occurred within 30 days. All
four proximal endoleaks were associated with technical issues that
resulted in procedure reﬁnement, and all were in patients with
adverse proximal aortic necks. Following treatment with trans-
catheter embolization, the persistent Type 1 endoleak rate at 30
days was 0%. There were no Type 2 or Type 3 endoleaks. Angio-
plasty and adjunctive stenting were performed for postoperative
limb stenosis in three patients (3%).
EVAS is associated with reasonable 30-day outcomes, with
applicability to patients with challenging aortic morphology.
Endoleak rates should reduce with procedural experience. The
utility of EVAS will be deﬁned its durability in long-term follow-up,
although the absence of Type 2 endoleaks is encouraging.A 19-year Experience of Secondary Interventions Following EVAR
A. Burdess, M.J. Clarke, M.G. Wyatt
The Freeman Hospital, Newcastle, UK
EVAR is increasingly used as the primary mode of treatment for
aneurysmal disease. However, this technique is associated with
complications that mandate life-long follow up. We present a 19-
year single-centre experience with EVAR, speciﬁcally examining the
indications for re-intervention and the methods used.
A retrospective analysis was conducted of all EVAR cases per-
formed at the Freeman Hospital from 1995e2014.
In a 19-year period 1100 standard EVARs were performed (947
abdominal; 161 thoracic). There were a total of 303 re-in-
terventions in 212 patients (19%). Indications for re-intervention
included: Endoleak (n ¼ 180; 16%); sac expansion without endo-
leak (n ¼ 38; 14%); limb occlusion (n ¼ 40; 0.03%); disease pro-
gression (n ¼ 28; 0.03%) and rupture (n ¼ 10; 0.9%).
